Vanguard Group Inc. Sells 37,508 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Vanguard Group Inc. trimmed its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,692,763 shares of the company’s stock after selling 37,508 shares during the quarter. Vanguard Group Inc. owned about 11.47% of Prestige Consumer Healthcare worth $325,569,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of PBH. Advisor Group Holdings Inc. increased its stake in Prestige Consumer Healthcare by 10.9% during the 1st quarter. Advisor Group Holdings Inc. now owns 3,694 shares of the company’s stock valued at $196,000 after purchasing an additional 363 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Prestige Consumer Healthcare by 10.8% during the 1st quarter. JPMorgan Chase & Co. now owns 210,242 shares of the company’s stock valued at $11,130,000 after purchasing an additional 20,496 shares in the last quarter. Raymond James & Associates increased its stake in Prestige Consumer Healthcare by 84.8% during the 1st quarter. Raymond James & Associates now owns 9,326 shares of the company’s stock valued at $494,000 after purchasing an additional 4,279 shares in the last quarter. US Bancorp DE increased its stake in Prestige Consumer Healthcare by 67.7% during the 1st quarter. US Bancorp DE now owns 10,237 shares of the company’s stock valued at $541,000 after purchasing an additional 4,132 shares in the last quarter. Finally, HighTower Advisors LLC increased its stake in Prestige Consumer Healthcare by 6.0% during the 1st quarter. HighTower Advisors LLC now owns 5,791 shares of the company’s stock valued at $307,000 after purchasing an additional 330 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, SVP Mary Beth Fritz sold 5,336 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $69.00, for a total value of $368,184.00. Following the transaction, the senior vice president now owns 15,934 shares of the company’s stock, valued at $1,099,446. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms have weighed in on PBH. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, February 10th. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research note on Monday, February 12th. One investment analyst has rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $110.00.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE PBH opened at $72.70 on Thursday. The firm’s 50-day moving average price is $68.37 and its 200-day moving average price is $62.46. The company has a quick ratio of 1.92, a current ratio of 3.09 and a debt-to-equity ratio of 0.75. The company has a market cap of $3.61 billion, a PE ratio of -44.33, a PEG ratio of 2.07 and a beta of 0.52. Prestige Consumer Healthcare Inc. has a 52-week low of $55.96 and a 52-week high of $75.31.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, February 8th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.02. The company had revenue of $282.74 million for the quarter, compared to the consensus estimate of $280.25 million. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. The firm’s revenue was up 2.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.04 earnings per share. As a group, analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.33 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.